Urolithins: Potential Biomarkers of Gut Dysbiosis and Disease Stage in Parkinson’s Patients
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
). Besides, their microbiome was characterized by predictive functions of lipopolysaccharide biosynthesis and metabolism of glutathione, cysteine and methionine that could indirectly reflect the gut pro-inflammatory status. Urolithin detection in urine is a feasible, non-invasive and fast approach that can reflect gut microbiome dysbiosis and intestinal inflammation in Parkinson's disease patients. Our current study could provide novel strategies for improving diagnostics, and for preventing and treating disease progression in microbiota-based interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“because of dysbiosis, lipid, amino acid and energy metabolism are often dysregulated in PD patients [96,97,98,99,100]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [100]
In the citing paper
“disease severity has been associated with lower urine levels of urolithin, an anti-inflammatory molecule produced by the gut microbiota upon polyphenols intake [100]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [100]
Citations
Cites
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Challenges in the diagnosis of Parkinson's disease
Tolosa, E., Garrido, A., Scholz, S. W., & Poewe, W. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00030-2 · Cited by 1,874
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Current Understanding of Dysbiosis in Disease in Human and Animal Models
DeGruttola, A. K., Low, D., Mizoguchi, A., & Mizoguchi, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000750 · Cited by 1,122
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Lewis, J. D., Chen, E. Z., Baldassano, R. N., Otley, A. R., Griffiths, A. M., Lee, D., Bittinger, K., Bailey, A., Friedman, E. S., Hoffmann, C., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.09.008 · Cited by 823
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Maini Rekdal, V., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J., & Balskus, E. P. (2019) · Science · doi:10.1126/science.aau6323 · Cited by 753
Larrosa, M., González-Sarrías, A., Yáñez-Gascón, M. J., Selma, M. V., Azorín-Ortuño, M., Toti, S., Tomás-Barberán, F., Dolara, P., & Espín, J. C. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.012 · Cited by 504
Self-citationDysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445
Research works printed but not linked: 4
- Hill, 2021, Front. Neurosci., 15, 1
- Sun, 2018, Ageing Res. Rev., 45, 53, 10.1016/j.arr.2018.04.004 · DOI · Paper page
- Smirnova, 2005, Biochemistry, 70, 1199
- Zheng, 2017, Front. Microbiol., 8, 1
Cited by
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175
Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 159
Approach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 91
(Poly)phenol-related gut metabotypes and human health: an update
Hu, J., Mesnage, R., Tuohy, K. M., Heiß, C., & Rodriguez‐Mateos, A. (2024) · Food & Function · doi:10.1039/d3fo04338j · Cited by 91
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia
Deng, W., Yi, P., Xiong, Y., Ying, J., Lin, Y., Dong, Y., Wei, G., Wang, X., & Hua, F. (2023) · Aging and Disease · doi:10.14336/ad.2023.0727 · Cited by 72
Mateș, L., Banc, R., Zaharie, F. A., Rusu, M. E., & Popa, D. (2024) · Antioxidants · doi:10.3390/antiox13080974 · Cited by 53
Ren, D., Ding, M., Su, J., Ye, J., He, X., Zhang, Y., & Shang, X. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.009 · Cited by 44
Zhang, H., Li, C., Han, L., Xiao, Y., Bian, J., Liu, C., Gong, L., Liu, Z., & Wang, M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2367342 · Cited by 40
Iglesias‐Aguirre, C. E., González‐Sarrías, A., Cortés‐Martín, A., Romo‐Vaquero, M., Osuna‐Galisteo, L., Cerón, J. M. C., Espín, J. C., & Selma, M. V. (2023) · Food & Function · doi:10.1039/d2fo03957e · Cited by 40
Self-citationUrolithin A in Health and Diseases: Prospects for Parkinson’s Disease Management
Wojciechowska, O., & Kujawska, M. (2023) · Antioxidants · doi:10.3390/antiox12071479 · Cited by 40
Chatterjee, A., Kumar, S., Sarkar, S. R., Halder, R., Kumari, R., Banerjee, S., & Sarkar, B. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109622 · Cited by 39
Promotion of Healthy Aging Through the Nexus of Gut Microbiota and Dietary Phytochemicals
Beaver, L. M., Jamieson, P. E., Wong, C. P., Hosseinikia, M., Stevens, J. F., & Ho, E. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100376 · Cited by 37
Marć, M. A., Jastrząb, R., & Mytych, J. (2022) · Nutrients · doi:10.3390/nu14193967 · Cited by 36
Ribeiro, M. M., Alvarenga, L., Cardozo, L., Baptista, B. G., Nascimento, D., Esgalhado, M., & Mafra, D. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00645-0 · Cited by 35
Dietary (Poly)phenols and the Gut–Brain Axis in Ageing
Láng, L., McArthur, S., Lázár, A. S., Pourtau, L., Gaudout, D., Pontifex, M. G., Müller, M. M., & Vauzour, D. (2024) · Nutrients · doi:10.3390/nu16101500 · Cited by 34
Espín, J. C., Jarrín‐Orozco, M. P., Osuna‐Galisteo, L., Ávila‐Gálvez, M. Á., Romo‐Vaquero, M., & Selma, M. V. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400526 · Cited by 32
Self-citationUrolithins: A Prospective Alternative against Brain Aging
An, L., Lu, Q., Wang, K., & Wang, Y. (2023) · Nutrients · doi:10.3390/nu15183884 · Cited by 31
Zhang, P., Huang, P., Li, Y., Du, J., Luo, N., He, Y., Liu, J., He, G., Cui, S., Zhang, W., et al. (2024) · Aging and disease · doi:10.14336/ad.2023.0518 · Cited by 30
Zhao, R., Mu, B., Wang, D., XinHuang, Ma, Q., & Lu, M. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04584-9 · Cited by 30
Anghel, A. C., Țăranu, I., Orțan, A., Spinu, S. M., Cudalbeanu, M. D., Rosu, P. M., & Babeanu, N. E. (2024) · Molecules · doi:10.3390/molecules29246026 · Cited by 25
Faizan, M., Sarkar, A., & Singh, M. P. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101727 · Cited by 25
Sheng, D., Li, P., Xiao, Z., Li, X., Liu, J., Xiao, B., Liu, W., & Zhou, L. (2024) · SLEEP · doi:10.1093/sleep/zsae004 · Cited by 22
Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy
Rodríguez-García, A., Ancos-Pintado, R., García-Vicente, R., Ortiz-Ruiz, A., Arroyo, A., Navarro, M. A., Morales, M. L., Guevara‐Ramírez, P., Justo, P., López‐Muñoz, N., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02045-6 · Cited by 20
Self-citationXie, Z., Chen, F., Xiao, Y., You, J., Zhou, X., Li, P., Zhou, Q., & Ruan, Z. (2025) · Food & Function · doi:10.1039/d4fo06221c · Cited by 16
Widjaja, F., & Rietjens, I. M. C. M. (2023) · Biomedicines · doi:10.3390/biomedicines11102658 · Cited by 13
Therapeutic efficacy of gut microbiota-derived polyphenol metabolite Urolithin A
Shetty, S. S., Shetty, S., & Kumari, S. (2024) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-024-00492-y · Cited by 11
Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder
Vashishth, S., Ambasta, R. K., & Kumar, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102466 · Cited by 9
Huang, Z., Ren, Z., Wang, S., Xiao, L., Ling, Y., Xie, Y., Wang, G., & Zhou, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-93554-9 · Cited by 9
Connell, E., Gall, G. L., McArthur, S., Láng, L., Breeze, B., Pontifex, M. G., Sami, S. A. K., Pourtau, L., Gaudout, D., Müller, M. M., et al. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105878 · Cited by 8
Devi, A., Munagalasetty, S., Kumar, P., Kumar, R. K., Bhandari, V., & Dandekar, M. P. (2025) · NeuroToxicology · doi:10.1016/j.neuro.2025.04.009 · Cited by 8
Role of the Intestinal Microbiota in the Molecular Pathogenesis of Atypical Parkinsonian Syndromes
Przewodowska, D., Alster, P., & Madetko‐Alster, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093928 · Cited by 6
Hu, Y., Wang, H., Zhong, Y., & Sun, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38645 · Cited by 6
A review on the metabolism and anti-allergic effects of ellagitannins
Zhang, P., Zhang, N., Huang, L., Xia, N., & Teng, J. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2520393 · Cited by 4
Examination of shared gut microbiome signatures in aging and Parkinson’s disease
Tng, T. J. W., Vanan, S., Tan, E.-K., Zeng, L., Goh, W. W. B., Wong, H. S., & Lim, K. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1745455 · Cited by 3
Improved Key Microbial Biomarker Discovery Using Ensemble Statistical Methods
Pirovano, W., Gangopadhyay, Y., Baak, M. L., de Leeuw, C., Bongoni, R., & Klaassens, E. S. (2025) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/9676659 · Cited by 3
Vita, A. A., Brown, J., Norby-Adams, L., Ghanem, N., Weir, T. L., & Goldenberg, J. Z. (2026) · Journal of Nutrition · doi:10.1016/j.tjnut.2026.101700 · Cited by 3
Devi, A., Singh, S. B., Srivastava, S., & Dandekar, M. P. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00362 · Cited by 3
Hou, T., Peng, Z., Chen, Y., Feng, Y., Hou, X., & Mao, Y.-H. (2026) · Food & Function · doi:10.1039/d5fo02826d · Cited by 2
Brown, J., Norby-Adams, L., Ghanem, N., Lewis, A., Goldenberg, J. Z., Weir, T., & Vita, A. A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1859472 · Cited by 2
Wu, J., Ye, X., Hua, W., Yao, Y., Sun, L., Ma, H., Yu, C., Cheng, Y., & Mi, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12542-y · Cited by 2
The gut–brain axis in narcolepsy: emerging research on microbiota, diet, and sleep
Xiao, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30004-2.00004-3 · Cited by 1
Correlation between depressive-like behavior and gut microbiota in mice with hypothyroidism
Guo, H.-J., Ma, X., Li, Y., Zhou, Z.-H., Tao, W., Jiang, Y.-H., Li, X., & Zhang, X.-L. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i7.104921 · Cited by 1
Zhang, H., Li, Z., Xiao, Y., Bian, J., He, C., Liu, C., Gong, L., Han, L., Liu, Z., & Wang, M. (2026) · Advanced Science · doi:10.1002/advs.202508048 · Cited by 1
Connell, E. (2025) · UEA Digital Repository (University of East Anglia) · Cited by 1
Oswal, D. G., & Rane, M. M. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106224 · Cited by 1
Galkina, P. А., Domínguez‐López, I., Cofán, M., Pozzoli, C., Vallverdú‐Queralt, A., Serra‐Mir, M., Chiva‐Blanch, G., Rajaram, S., Sabaté, J., Sala‐Vila, A., et al. (2026) · Food & Function · doi:10.1039/d6fo02116f · Cited by 1
Wang, W., Sun, W., Ma, L., Xu, M., & Dong, X. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1889517
Beyond bacteria: a multi-omics view of the gut–brain axis in Parkinson’s disease
Han, H., Luo, O., Li, K., Rahaman, S., Ok, E. U., Zhang, L., Liang, M., & Huang, L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1900578
Shokr, M. M., & Fawzy, M. N. (2026) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2026.104112
Rodriguez‐Mateos, A., Kamarunzaman, N. N. Z., Lu, T., Baya, M., Powell, C., Li, Y., Mesnage, R., Alharbi, A., Halket, J. M., Caldwell, A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10739217/v1
Alikunju, A. P., Jose, D. A., Venkatachalam, S., Tajudeen, J., Vasu, D. A., K, D. K., Raman, G., Gayathri Thankam, L., Thomas, F., P, D. K., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01547-w
Chen, Q.-Q., Gou, D.-H., Huang, J.-Y., Mo, Z.-H., Guan, X.-Y., & Xu, J.-N. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1763253
Xie, Z., Dai, X., You, J., Yao, Z., Xiao, M., Huang, S., Liu, Q. H., & Ruan, Z. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109245
Decoding the Gut-Brain Axis: Implications for Neurodegenerative Disease Therapies
(2026) · Frontiers research topics · doi:10.3389/978-2-8325-8753-9
Mai, J., Luo, W., Zhao, Y., Liu, K., Chen, Y., Yao, R., & Li, M. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110404
The Gut-Brain Axis in Neurodegeneration: Mechanistic Insights and Emerging Therapeutic Perspectives
Marathe, H., Darade, A., Mahajan, M., Upaganlawar, A., & Upasani, C. (2026) · Yemen Journal of Medicine · doi:10.63475/yjm.v5i1.0295
Gątarek, P., & Kałużna‐Czaplińska, J. (2026) · Applied Sciences · doi:10.3390/app162211317
Nutrition Interventions for Healthy Ageing
Dramé, M., & Godaert, L. (2025) · MDPI eBooks · doi:10.3390/books978-3-7258-2716-9
Metadata
- Authors
- Romo-Vaquero, M., Fernández-Villalba, E., Gil-Martinez, A.-L., Cuenca-Bermejo, L., Espín, J. C., Herrero, M. T., & Selma, M. V.
- Affiliations
- Laboratory of Food & Health, Research Group on Quality, Safety and Bioactivity of Plant Foods, CEBAS-CSIC, Campus de Espinardo, Murcia 30100, Spain
- Institute of Biomedical Research of Murcia (IMIB), Campus de Ciencias de la Salud, Carretera Buenavista s/n, El Palmar, Murcia 30120, Spain
- Instituto Murciano de Investigación Biosanitaria (ES)
- Corresponding author
- Herrero, María Trinidad
- Venue
- Food & Function
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2022
- Volume
- 13
- Issue
- 11
- Pages
- 6306-6316
- ISSN
- 2042-6496 (ISSN-L)
- 2042-650X
- OpenAlex
- W4282928102
- Cited by
- 54
- References
- 44
- Citations by year
- 2026: 16 · 2025: 11 · 2024: 16 · 2023: 7 · 2022: 4
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Food & Function (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by-nc)
- Hispana (submittedVersion, cc-by-nc-nd)
- Funders
- Consejo Superior de Investigaciones Científicas (PIE201570I005)
- Fundación Séneca (FS/20880/PI/18)
- Ministerio de Ciencia e Innovación (AGL2015-64124-R and PID2019-103914RB-I00)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Nursing › Nutrition and Dietetics › Pomegranate: compositions and health benefits
- Keywords
- urolithins, Parkinson's disease, gut dysbiosis, gut microbiota, biomarkers, disease stage, intestinal inflammation, lipopolysaccharide biosynthesis, glutathione metabolism, cysteine and methionine metabolism, urinary biomarkers, non-invasive diagnosis, microbiota-targeted interventions
- MeSH terms
- Gastrointestinal Microbiome, Bacteria, Humans, Parkinson Disease, Biomarkers, Juglans, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.